US Stock MarketDetailed Quotes

MED Medifast

Watchlist

18.840
+0.110+0.59%

Close Jul 24 16:00 ET

18.930
+0.090+0.48%

Post 19:53 ET

206.06MMarket Cap3.04P/E (TTM)

Medifast Stock Forum

doge1m

Jul 12 11:34

$Medifast(MED.US)$ what's going on here we're getting shorted? This is a great company let's go $20

Ann_Doe

Jun 12 16:04

Interesting

$Medifast(MED.US)$ wow, so many shorted 🧐

Insider share sale and more insider sales than purchases over the past year may raise concerns. Low insider ownership in Medifast could suggest a lack of long-term incentive to grow the company.

Independent Director Scott Schlackman Sold A Bunch Of Shares In Medifast

Jaymonie

Feb 21 07:02

LOW FLOAT Squeeze $med

$NVIDIA(NVDA.US)$
check out this company!!
$Medifast(MED.US)$
96.7% institutional ownership
17.9% float sold short
p/e ratio: 4.46
dividend: 13%
0 debt
150 m in cash
established: 1981
$Tesla(TSLA.US)$

Moomoo AI

Feb 20 15:52

Medifast's decision to increase marketing spending amid demand headwinds has alarmed investors, leading to a 10.1% drop in the company's stock price, despite exceeding revenue expectations.

Medifast (NYSE:MED) Exceeds Q4 Expectations But Stock Drops 10.1%

Moomoo AI

Feb 6 08:43

Medifast's low P/E ratio is likely due to market anticipation of continued poor earnings. The weak earnings outlook is pressuring the stock price downwards. Without improvement, the low P/E ratio and stock price may not rise.

Insufficient Growth At Medifast, Inc. (NYSE:MED) Hampers Share Price

Moomoo AI

Jan 10 05:06

Recent insider buying at Medifast isn't a strong indicator of stock potential. Modest insider ownership suggests some alignment between management and smaller shareholders, but overall analysis leaves a cautious outlook on the stock.

This Medifast Insider Reduced Their Stake By 72%

Moomoo AI

Dec 13, 2023 05:10

Medifast's CEO, Dan Chard, suggests firms lacking a GLP-1 weight-loss related strategy could face struggles to remain relevant. This comes as the company's revenue fell and the stock decreased by 35% year-to-date.

Diet Company Medifast, Once an Ozempic Skeptic, Embraces Weight-Loss Drugs With New Deal -- WSJ

Moomoo AI

Dec 9, 2023 08:10

Despite Medifast trading below industry PE ratio, the prospect of negative growth poses risk. Investors should evaluate considering the price multiple and forecasted earnings decline.

When Should You Buy Medifast, Inc. (NYSE:MED)?

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall